Record #:
					ONT0166
				
				
					Last Full Update:
					06 Nov 2024
				
			 
		 
	 
 
	
		
			
				
Contact Information
			
			
				
					
					
					
						| Office Phone | 416-410-1740 | 
					
					
					
						| Toll Free Phone | 1-877-410-1741 | 
					
					
						| E-Mail | endpkd@endpkd.ca | 
					
					
						| Website | www.endpkd.ca/ | 
					
					
						| Primary Contact | Vilija Batten, Foundation Coordinator | 
				
			 
		 
		
			
				
Agency Information
			
			
				
					
					
						| Legal Status | (50) Non Profit | 
					
					
						| Primary Executive | Kathleen Barnard, Executive Director | 
					
					
					
						| Funding | Private - Donations | 
				
			 
		 
		
			
				
Description and Service Details
			
			
				
					
					
					
						| Description (Service) | Support and help for people living with poylcystic kidney disease (PKD) and their families * funds research into PKD * education, advocacy and awareness of PKD * monthly newsletters | 
					
					
					
						| Hours | Mon-Fri 9am-5pm | 
					
					
					
						| Areas Served | Canada | 
					
					
					
						| Boundaries | Canada | 
					
					
					
						| Eligibility | People living with poylcystic kidney disease (PKD) and their families | 
					
					
					
						| Application | Call or visit website | 
					
					
					
						| Languages | English ; French | 
				
			 
		 
		
			
				
Site Information
			
			
				
					
					
					
						| Site Location | Toronto (Etobicoke City Centre) | 
					
					
					
						| Located In Community | Etobicoke Central | 
					
					
					
						| Address & Map | 3-1750 The Queensway, Suite 158Etobicoke, ON     M9C 5H5
 | 
					
					
					
						| Intersection | Hwy 427 and The Queensway | 
					
					
					
						| Physical Access | Not Accessible | 
				
			 
		 
		
			
				
Categories and Classification
			
			
		 
	 
 
		
		
			
			Any omissions are unintentional and HIP disclaims any liability for unauthorized use or reproduction of any portion of this site. For a complete copyright and license statement please refer to our Terms of Use.